William Mack & Associates
CME icon

William Mack & Associates’s CME Group CME Stock Holding History

William Mack & Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.14K Buy
+12
New +$3.16K ﹤0.01% 495

Other funds holding CME

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

William Mack & Associates's CME Position: Q3 2026 in Review

William Mack & Associates opened a new position in CME Group (CME) in Q3 2026: 12 shares worth $3.14K. The stake represents ﹤0.01% of the portfolio and ranks #495 among its holdings.

1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • William Mack & Associates held 12 shares of CME Group worth $3.14K as of Q3 2026.
  • CME Group was a new William Mack & Associates position in Q3 2026.
  • CME Group made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #495 holding.
  • 1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.